These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 22589460)

  • 1. Determination of factor V Leiden mutation and R2 polymorphism in cis position.
    Oztürk A; Balli S; Akar N
    Clin Appl Thromb Hemost; 2013; 19(6):685-8. PubMed ID: 22589460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective screening for the Factor V Leiden mutation: is it advisable prior to the prescription of oral contraceptives?
    Schambeck CM; Schwender S; Haubitz I; Geisen UE; Grossmann RE; Keller F
    Thromb Haemost; 1997 Dec; 78(6):1480-3. PubMed ID: 9423798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prothrombin polymorphism A19911G, factor V HR2 haplotype A4070G, and plasminogen activator-inhibitor-1 polymorphism 4G/5G and the risk of retinal vein occlusion.
    Kuhli-Hattenbach C; Hellstern P; Nägler DK; Kohnen T; Hattenbach LO
    Ophthalmic Genet; 2017; 38(5):413-417. PubMed ID: 28085526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Probability of recurrence of thrombosis in patients with and without factor V Leiden.
    Rintelen C; Pabinger I; Knöbl P; Lechner K; Mannhalter C
    Thromb Haemost; 1996 Feb; 75(2):229-32. PubMed ID: 8815565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of the 4600A/G and 4678G/C polymorphisms in the endothelial protein C receptor (EPCR) gene on the risk of venous thromboembolism in carriers of factor V Leiden.
    Medina P; Navarro S; Estellés A; Vayá A; Bertina RM; España F
    Thromb Haemost; 2005 Aug; 94(2):389-94. PubMed ID: 16113830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The HR2 haplotype of factor V: effects on factor V levels, normalized activated protein C sensitivity ratios and the risk of venous thrombosis.
    de Visser MC; Guasch JF; Kamphuisen PW; Vos HL; Rosendaal FR; Bertina RM
    Thromb Haemost; 2000 Apr; 83(4):577-82. PubMed ID: 10780320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The factor V gene A4070G mutation and the risk of venous thrombosis.
    Alhenc-Gelas M; Nicaud V; Gandrille S; van Dreden P; Amiral J; Aubry ML; Fiessinger JN; Emmerich J; Aiach M
    Thromb Haemost; 1999 Feb; 81(2):193-7. PubMed ID: 10063990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factor V gene A4070G mutation and the risk of cerebral veno-sinus thrombosis occurring during puerperium.
    Dindagur N; Kruthika-Vinod TP; Christopher R
    Thromb Res; 2007; 119(4):497-500. PubMed ID: 16781765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case control study of deep venous thrombosis in relation to factor V G1691A (Leiden) and A4070G (HR2 Haplotype) polymorphisms.
    Bouaziz-Borgi L; Nguyen P; Hezard N; Musharrafieh U; Almawi WY; Mahjoub T
    Exp Mol Pathol; 2007 Dec; 83(3):480-3. PubMed ID: 17555744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hereditary protein C deficiency and thrombosis risk: genotype and phenotype relation in a large Italian family.
    Cafolla A; D'Andrea G; Baldacci E; Margaglione M; Mazzucconi MG; Foà R
    Eur J Haematol; 2012 Apr; 88(4):336-9. PubMed ID: 22168450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prevalence of thrombophilic mutations of FV Leiden, prothrombin G20210A and PAl-1 4G/5G and their combinations in a group of 1450 healthy middle-aged individuals in the Prague and Central Bohemian regions (results of FRET real-time PCR assay)].
    Kvasnicka J; Hájková J; Bobcíková P; Kvasnicka T; Dusková D; Poletínová S; Kieferová V
    Cas Lek Cesk; 2012; 151(2):76-82. PubMed ID: 22515013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of the normal factor V allele modulates the APC resistance phenotype in heterozygous carriers of the factor V Leiden mutation.
    Brugge JM; Simioni P; Bernardi F; Tormene D; Lunghi B; Tans G; Pagnan A; Rosing J; Castoldi E
    J Thromb Haemost; 2005 Dec; 3(12):2695-702. PubMed ID: 16359508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical evaluation of a functional prothrombin time-based assay for identification of factor V Leiden carriers in a group of Italian patients with venous thrombosis.
    Gessoni G; Valverde S
    Blood Coagul Fibrinolysis; 2007 Oct; 18(7):603-10. PubMed ID: 17890946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Legg-Calve-Perthes disease, venous and arterial thrombi, and the factor V Leiden mutation in a four-generation kindred.
    Glueck CJ; Tracy T; Wang P
    J Pediatr Orthop; 2007; 27(7):834-7. PubMed ID: 17878795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations and polymorphisms in genes affecting haemostasis components in children with thromboembolic events.
    Komitopoulou A; Platokouki H; Kapsimali Z; Moschovi M; Kattamis A; Pergantou H; Aronis S
    Pathophysiol Haemost Thromb; 2006; 35(5):392-7. PubMed ID: 17230042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factor V Leiden (FV R506Q) in families with inherited antithrombin deficiency.
    van Boven HH; Reitsma PH; Rosendaal FR; Bayston TA; Chowdhury V; Bauer KA; Scharrer I; Conard J; Lane DA
    Thromb Haemost; 1996 Mar; 75(3):417-21. PubMed ID: 8701400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prothrombin A19911G polymorphism and the risk of venous thromboembolism.
    Martinelli I; Battaglioli T; Tosetto A; Legnani C; Sottile L; Ghiotto R; Mannucci PM
    J Thromb Haemost; 2006 Dec; 4(12):2582-6. PubMed ID: 16981886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factor V Leiden (Arg506Gln), a confounding genetic risk factor but not mandatory for the occurrence of venous thromboembolism in homozygotes and obligate heterozygotes for cystathionine beta-synthase deficiency.
    Yap S; O'Donnell KA; O'Neill C; Mayne PD; Thornton P; Naughten E
    Thromb Haemost; 1999 Apr; 81(4):502-5. PubMed ID: 10235428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular characterization of a type I quantitative factor V deficiency in a thrombosis patient that is "pseudo homozygous" for activated protein C resistance.
    Guasch JF; Lensen RP; Bertina RM
    Thromb Haemost; 1997 Feb; 77(2):252-7. PubMed ID: 9157576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selectin haplotypes and the risk of venous thrombosis: influence of linkage disequilibrium with the factor V Leiden mutation.
    Uitte de Willige S; De Visser MC; Vos HL; Houwing-Duistermaat JJ; Rosendaal FR; Bertina RM
    J Thromb Haemost; 2008 Mar; 6(3):478-85. PubMed ID: 18182036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.